Editas Medicine
EDIT
226 hedge funds and large institutions have $504M invested in Editas Medicine in 2024 Q1 according to their latest regulatory filings, with 38 funds opening new positions, 73 increasing their positions, 62 reducing their positions, and 35 closing their positions.
106% more call options, than puts
Call options by funds: $5.57M | Put options by funds: $2.71M
18% more repeat investments, than reductions
Existing positions increased: 73 | Existing positions reduced: 62
11.03% more ownership
Funds ownership: 72.01% → 83.04% (+11%)
9% more first-time investments, than exits
New positions opened: 38 | Existing positions closed: 35
0% more funds holding
Funds holding: 226 → 226 (0)
15% less capital invested
Capital invested by funds: $596M → $504M (-$92M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$30.7M |
| 2 |
Goldman Sachs
New York
|
+$7.04M |
| 3 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$5.5M |
| 4 |
Millennium Management
New York
|
+$5.37M |
| 5 |
Citigroup
New York
|
+$4.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$5.88M |
| 2 |
Voloridge Investment Management
Jupiter,
Florida
|
-$4.27M |
| 3 |
Marshall Wace
London,
United Kingdom
|
-$2.66M |
| 4 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$2.15M |
| 5 |
TCM
Tang Capital Management
San Diego,
California
|
-$2.03M |
EDIT Hedge Fund Activity: Q1 2024 in Review
226 of the 6,958 institutional investors tracked by Wall St. Rank reported a position in Editas Medicine (EDIT) for Q1 2024, worth a combined $504M — down 15% from $596M a quarter earlier.
Buyers outnumbered sellers: 38 funds opened new EDIT positions and 35 closed out — a net gain of 3 holders — while 73 added to existing stakes and 62 trimmed.
The largest buyer was State Street, adding an estimated $30.7M. The largest seller was Point72 Asset Management, exiting entirely with an estimated $5.88M sold.
- 226 institutional investors held Editas Medicine (EDIT) as of Q1 2024, unchanged from Q4 2023.
- Funds reported $504M of Editas Medicine stock for Q1 2024, down 15% quarter-over-quarter.
- 38 funds opened new Editas Medicine positions in Q1 2024 and 35 closed out, a net change of +3 holders.
- The largest Editas Medicine buyer in Q1 2024 was State Street, an estimated $30.7M added.
- The largest Editas Medicine seller in Q1 2024 was Point72 Asset Management, an estimated $5.88M sold.
Based on aggregated 13F filings for Q1 2024.